OBJECTIVE: We reviewed the evidence for an intrinsic ovarian renin-angiotensin system (OVRAS), highlighting potential diverse signaling in this system through different bioactive angiotensin peptides, their specific receptors, and second messengers. In addition, sites of action for O VRAS in the regulation of ovarian function in health and disease were reviewed.
DATA SOURCES : We used published journals and abstracts from national scientific meetings. Current developments in the renin-angiotensin field are historically set.
STUDY SELECTION: One hundred referenced articles provided studies on renin-angiotensin systems in mammalian species, including humans.
DATA ABSTRACTION: Interpretation of the reviewed publications was in line with the orig inal authors' conclusions and statistical analysis.
DATA SYNTHESIS: Techniques in molecular biology, biochemistry, and immunohistochemis try have identified an O VRAS in mammalian species. Ovarian tissues contain all the elements for the production of angiotensin, including prorenin/renin, angiotensinogen, and angiotensin- converting enzyme. In addition, angiotensin II is present in ovarian compartments, and receptors for angiotensin II are demonstrated on specific ovarian cells. Angiotensin II is implicated to play a role in ovulation, steroidogenesis, follicular atresia, and hyperandrogenic syndromes.
CONCLUSIONS: The newly identified O VRAS may have important actions in the ovary that range from regulation of ovulation to ovarian dysfunction, such as hyperandrogenic syndromes in women. In this respect, the O VRAS is a putative paracrine/autocrine regulator in the ovary, and pharmacologic regulation of the OVRAS may provide new methods for the management of fertility and reproduction. (J Soc Gynecol Invest 1994;1:118-27)
Tigerstedt R. , Bergman PGKidney and circulation. Scand Arch Physiol1898;8:223-71.
2.
Kem DC, Brown RDRenin—from beginning to end. N Engl J Med1990;323:1136-7.
3.
Burnham CE, Hawelu-Johnson CL, Frank BM, Lynch KRMolecular cloning of rat renin cDNA and its gene. Proc Natl Acad Sci USA1987;84:5605-9.
4.
Soubrier F., Panthier JJ, Hout AM, Rougen F., Corvol P.Segmental homology between the promoter region of the human renin gene and the mouse ren1 and ren2 promoter regions. Gene1986;41:85-92.
5.
Hobart PM, Fogliano M., O'Connor BA, Schaeffer IM, Chirgwin JMHuman renin gene: Structure and sequence analysis. Proc Natl Acad of Sci USA1984;81:5026-30.
6.
Hardman JA, Hort YJ, Catanzaro DF, et al. Primary structure of the human renin gene. DNA1984;3:457-68.
7.
Dzau VJ, Burt DW, Pratt REMolecular biology of the renin-angiotensin system. Am J Physiol1988 ;255:F563-73.
8.
Dzau VJ, Ellison KE, Brody T., Ingelfinger J., Pratt ERA comparative study of the distribution of renin and angiotensin messenger ribonucleic acids in rat and mouse tissues. Endocrinology1987;120:2334-8.
9.
Campbell DJ, Habener J.Angiotensinogen gene is expressed and differentially regulated in multiple tissues of the rat. J Clin Invest1986;78:31-9.
10.
Field LJ, McGowan RA, Dickinson DP, Gross KWTissue and gene specificity of mouse renin expression. Hypertension1984;6:597-603.
11.
Descepper CFThe renin-angiotensin system in the pituitary gland. Trends Endocrinol Metab1991;2:104-7.
12.
Weishaar RE , Panek RL, Major TC, Simmerman J., Rapundalo ST, Taylor Dgj.Evidence for a functional tissue renin-angiotensin system in rat mesenteric vasculature and its involvement in regulating blood pressure. J Pharmacol Exp Ther1991;256:568-74.
13.
Sramek SJ, Wallow IH, Day RP, Ehrlich ENOccular renin-angiotensin: Immunohistochemical evidence for the presence of prorenin in eye tissue. Invest Opthalmol Vis Sci1988;29:1749-52.
14.
Eskildsen PCLocalization of renin in rabbit uterus by help of microdissection. Acta Pathol Microbiol Scand1972;80:241-52.
15.
Regoli D., Park WK, Rioux F.Pharmacology of angiotensin. Pharmacol Rev1974;26:69-123.
16.
Skeggs LT, Dorer FE, Levine M., Lentz KE, Kahn JRThe biochemistry of the renin-angiotensin system. In: Johnson A, Anderson RR, ed. The renin-angiotensin system. New York: Plenum Press, 1980:1-16.
17.
Britton KERenin and renal autoregulation. Lancet1968 :ii:329-33.
18.
Peart WSThe renin-angiotensin system. A history and review of the renin-angiotensin system. Proc R Soc Biol Sci1969;173:318-25.
19.
Katt KJABC of endocrinology. V. Adrenal cortex. Lancet1970;ii:1275-83.
20.
Kohara K., Brosnihan KB, Chappel MC, Khosla MC, Ferrario CMAnglotensin-(1-7): A member of circulating angiotensin peptides. Hypertension1991;17:131-8.
21.
Leyssac PPIntrarenal function of angiotensin. Fed Proc1967;26:55-9.
22.
Santos Ras , Brosnihan KB, Jacobsen DW, DiCorletto PE, Ferrario CMProduction of angiotensin-(1-7) by human vascular endothelium. Hypertension1992;19(suppl II):II-56-61.
23.
Santos Ras , Brosnihan KB, Chappell MC, et al. Converting enzyme activity and angiotensin metabolism in the dog brainstem. Hypertension1988;11(suppl I):I-153-7.
24.
Brunner HR , Waeber B., Nussberger J.What we would like to know about the antihypertensive mechanisms of angiotensin converting enzyme inhibitors. J Hypertens1988;6:S1-5.
25.
Ferrario CM , Brosnihan KB, Diz DI, et al. Angiotensin-(1-7): A new hormone of the angiotensin system. Hypertension1991;18(suppl III):III-126-33.
26.
Santos Mjc, Diz DI, Santos Ras, Khosla MC, Brosnihan KB, Ferrario CMCardiovascular effects of angiotensin-(1-7) injected into the dorsal medulla of rats. Am J Physiol1989;257:H324-9.
27.
Goodfriend TLAngiotensins: A family that grows from within . Hypertension1991;17:139-40.
Van Sande ME , Scharpe SL, Neels HM, Van Camp KODistribution of angiotensin converting enzyme in human tissues. Clin Chim Acta1985;147:255-60.
30.
Itskovitz J. , Sealey JE, Glorioso N., Laragh JH, Rosenwaks Z.The ovarian prorenin-angiotensin system. Ann NY Acad Sci1988;541:179-89.
31.
Glorioso N. , Atlas SA, Laragh JH, Jewelewicz R., Sealey Jje.Prorenin in high concentrations in human ovarian follicular fluid. Science1986;233:1422-4.
32.
Fernandez AL , Tarlatzis V., Rzaza PJ, DeCherney AJ, Naftolin F.Renin-like activity in ovarian follicular fluid. J Clin Endocrinol Metab1985;44:219-23.
33.
Do YS, Sherrod A., Lobo RA, et al. Human ovarian theca cells are a source of renin. Proc Natl Acad Sci USA1988; 85:1957-61.
34.
Culler MD, Tarlatzis BC, Lightman A., et al. Angiotensin II-like immunoreactivity in human ovarian follicular fluid. J Clin Endocrinol Metab1986;62:613-5.
35.
Lightman A. , Palumbo A., DeCherney AH, Naftolin N.The ovarian renin-angiotensin system. Semin Reprod Endocrinol1989;7:79-87.
36.
Tang SS, Loscalzo J., Dzau VJTissue plasminogen activator activates the renin angiotensin system . Hypertension1987;10:355.
37.
Kim SJ, Shinjo M., Fukamizu H., Usuki S., Murakami K.Identification of renin and renin messenger RNA sequence in rat ovary and uterus. Biochem Biophys Res Commun1987 ;142:169.
38.
Lightman A. , Deschepper CF, Mellon SH, Ganong WF, Naftolin F.In situ hybridization identifies renin mRNA in the rat corpus luteum. GynecolEndocrinol1987 ;1:227-33.
39.
Itskovitz J. , Bruneval P., Soubrier F., Thaler I., Corvol P., Sealey Jej.Localization of renin gene expression to monkey ovarian theca cells by in situ hybridization . Clin Endocrinol Metab1992;75:1374-80.
40.
Palumbo A., Jones C., Lightman A., Carcangiu ML, DeCherney AH, Naftolin F.Immunohistochemical lo alization of renin and angiotensin II in human ovaries . Am J Obstet Gynecol1989;160:8-14.
Speth RC, Husain A.Distribution of angiotensin-converting enzyme and angiotensin II-receptor binding sites in the rat ovary. Biol Reprod1988;38:695-702.
43.
Husain A., Bumpus FM, DeSilva P., Speth C.Localization of angiotensin II receptors in ovarian follicles and the identification of angiotensin II in rat ovaries. Proc Natl Acad Sci USA1987;84:2489-93.
44.
Miyazaki H. , Kondoh M., Ohnishi J., Masuda Y., Hirose S., Murakami K.High-affinity angiotensin II receptors in the bovine ovary are different from those previously identified in other tissues . Biomed Res1988 ;9:281-5.
45.
Pepperell JR , Nemeth G., Yamada Y., Naftolin F.The type 1 angiotensin II receptor mediates intracellular calcium mobilization in rat luteal cells . Endocrinology1993;133: 1678-84.
46.
Wong PC, Price Waj, Chiu AT, et al. Non-peptide angiotensin II receptor antagonists. IV. EXP6155 and EP6803. Hypertension1989;13:489-97.
47.
Chiu AT, Herblin WF, McCall DE, et al. Identification of angiotensin II receptor subtypes. Biochim Biophys Res Commun1989;165:196-203.
48.
Chang Rsl, Lotti VJTwo distinct angiotensin II receptor binding sites in rat adrenal revealed by new selective non-peptide ligands. Mol Pharmacol1990;29:347-51.
49.
Catt KJ, Carson MC, Hausdorff WP, et al. Angiotensin receptors and mechanisms of action in adrenal glomerulosa cells. J Steroid Biochem1987;27:915-27.
50.
Jones C., Millan MA, Naftolin F., Aguilera G.Characterization of angiotensin II receptors in rat fetus. Peptides1989;10:459-63.
51.
Schirar A., Capponi A., Catt KJElevation of uterine angiotensin receptors during early pregnancy in the rat . Endocrinology1980;106:1521-7.
52.
Brunswig-Spickenheier B., Mukhopadhyay AKCharacterization of angiotensin-II receptor subtype on bovine thecal cells and its regulation by luteinizing hormone. Endocrinology1992 ;131:1445-52.
53.
Aguilera G. , Hyde C., Catt KJAngiotensin receptors and prolactin release in pituitary lactotrophs. Endocrinology1982 ;111:1045-50.
54.
Capponi AM, Catt KJSolubilization and characterization of adrenal and uterine angiotensin II receptors after photoaffinity labelling. J Biol Chem1980;255:12081-8.
55.
Pucell AG, Hodges JC, Sen I., Bumpus FM, Husain A.Biochemical properties of the ovarian granulosa cell type 2 angiotensin II receptor. Endocrinology1990;128:1947-59.
56.
Wang J., Baimbridge KG, Leung Pck.Perturbation of intracellular calcium ion concentration in single rat granulosa cells by angiotensin II. Endocrinology1989 ;124: 1094-6.
57.
Currie WD, Li W., Baimbridge KG, Yuen BH, Leung Pck.Cytosolic free calcium increased by prostaglandin F2α (PGF2α), gonadotropin-releasing hormone, and angiotensin II in rat granulosa cells and PGF2a in human granulosa cells. Endocrinology1992;130:1837-43.
58.
FloresJA, Veldhuis JD, Leong DAAngiotensin II induces calcium release in a subpopulation of single ovarian (granulosa) cells. Mol Cell Endocrinol1991 ;81:1-10.
59.
Sadrkhanloo R., Hofeditz C., Erickson GFEvidence for widespread atresia in the hypophysectomized estrogen-treated rat. Endocrinology1987;120:146-55.
60.
Putney JWA model for receptor-regulated calcium entry. Cell Calcium1986;7:1-12.
61.
Sealey JE, Glorioso N., Itskowitz J., Laragh JHProrenin as a reproductive hormone. Am J Med1986;81:1041-6.
62.
Liu Y-X.,Peng X-R. , Ny T.Tissue-specific and time-coordinated hormone regulation of plasminogen-activator-inhibitor type 1 and tissue-type plasminogen activator in the rat ovary during gonadotrophin-induced ovulation . Eur J Biochem1991;195:549-55.
63.
Cajander SB , Hugin MP, Kristensen P., Hsueh Ajw.Immunohistochemical localization of tissue-type plasminogen activator in ovaries before and after induced spontaneous ovulation in the rat. Cell Tissue Res1989;257:1-8.
64.
Apa R., Zreik T., Lightman A., et al. The ovarian renin-angiotensin system and compartmental function in the ovary. In: Mashiach S, Ben-Rafael Z, Laufer N, Schenker JG, eds. Advances in assisted reproductive technologies. New York: Plenum Press , 1990:147-51.
65.
Lightman A. , Tarlatzis BC, Rzasa PJ, et al. The ovarian renin-angiotensin system: Renin-like activity and angiotensin II/III immunoreactivity in gonadotrophin stimulated and unstimulated human follicular fluid. Am J Obstet Gynecol1987;156:808-14.
66.
Itskowitz J. , Sealey JE, Glorioso N., Rosenwaks Z.Plasma prorenin response to hCG in ovarian hyperstimulated women: Correlation with the number of ovarian follicles and steroid hormone concentrations. Proc Natl Acad Sci USA1987;84:7285-9.
67.
Brunswig-Spickenheier B., Mukhopadhyay AKInhibitory effects of a tumor-promoting phorbol ester on luteinizing hormone-stimulated renin and prorenin production by cultured bovine thecal cells. Endocrinology1990;127: 2157-65.
68.
Brunswig-Spickenheier B., Mukhopadhyay AKEffects of tumor necrosis factor-a on luteinizing hormone-stimulated prorenin production by bovine ovarian thecal cells in vitro . Endocrinology1993 ;133:2515-22.
69.
Kim S-J., Shinjo M., Tada M., et al. Ovarian renin gene expression is regulated by follicle stimulating hormone. Biochem Biophys Res Commun1987;146:989-95.
70.
DeVito E., Cabrera RR, Guardia DCChanges during lactation in the renin-like enzyme concentration in rat luteal tissue. Acta Endocrinol1987;116:526-30.
71.
DeVito E., Guardia DC, Cabrera RRA renin-like enzyme in rat luteal tissue: Evidence of local synthesis and its regulation during pregnancy. J Endocrinol1990;128:43-9.
72.
Fernandez LA , Twicler J., Mead A.Neovascularization produced by angiotensin II. J Lab Clin Med1985;105: 141-5.
73.
Frederick JL , Hoa N., Preston DS, et al. Initiation of angiogenesis by porcine follicular fluid. Am J Obstet Gynecol1985 ;152:1073-8.
74.
Frederick JL , Shimanuki T., DiZerega GSInitiation of angiogenesis by human follicular fluid. Science1984;24: 389-90.
75.
Sterling D. , Magness RR, Stone R., Waterman MR, Simpson ERAngiotensin II inhibits LH-stimulated cholesterol side chain cleavage expression and stimulates basic fibroblast growth factor expression in bovine luteal cells in primary culture. J Biol Chem1990;265:5-8.
76.
Williams GH , McDonnell LM, Raux MC, Hollenberg NKEvidence for different angiotensin II receptors in rat adrenal glomerulosa and rabbit vascular smooth muscle cells. Circ Res1974;34:384-90.
77.
Bumpus FM, Pucell AG, Daud AI, Husain A.Angiotensin II: An intraovarian regulatory peptide. Am J Med Sci1988;295:406-8.
78.
Pucell AG, Bumpus FM, Husain A.Regulation of angiotensin II receptors in cultured rat ovarian granulosa cells by follicle-stimulating hormone and Ang II. J Biol Chem1988;263:11954-61.
79.
Pellicer A. , Palumbo A., DeCherney AH, Naftolin F.Blockade of ovulation by an angiotensin antagonist . Science1988;240:1660-1.
80.
Kuo T-D., Endo K., Dharmarajan AM, Miyazaki T., Atlas SJ, Wallach EEDirect effect of angiotensin II on in vitro perfused rabbit ovary . J Reprod Fertil1991;92:469-74.
81.
Peterson CM , Zhu C., Mukaida T., Butler TA, Woessner Jjf, LeMaire WJThe angiotensin II antagonist, saralasin, inhibits ovulation in the perfused rat ovary. Am J Obstet Gynecol1993;168:242-5.
82.
Yoshimura Y. , Karube M., Koyama N., Shiokawa S., Nanno T., Nakamura Y.Angiotensin II directly induces follicle rupture and oocyte maturation in the rabbit. FEBS1992;307:305-8.
83.
Daud AI, Bumpus FM, Husain A.Angiotensin II. Does it have a direct obligate role in ovulation? Science1989;245: 870-1.
84.
Brannstrom M. , Janson POThe biochemistry of ovulation. In: Hillier SG, ed. Ovarian endocrinology . Oxford: Blackwell, 1991:133-66.
85.
Yoshimura Y. , Karube M., Oda T., et al. Locally produced angiotensin II induces ovulation by stimulating prostaglandin production in in vitro perfused rabbit ovaries. Endocrinology1993;133:1609-16.
86.
Peterson CM , Morioka N., Zhu C., Ryan JW, LeMaire WJAngiotensin-converting enzyme inhibitors have no effect on ovulation and ovarian steroidogenesis in the perfused rat ovary . Reprod Toxicol1993;7:131-5.
87.
Daud AI, Bumpus FM, Husain A.Evidence for the selective expression of angiotensin II receptors on atretic follicles in the rat ovary: An autoradiographic study. Endocrinology1988;122:2727-34.
88.
Armstrong DT , Siuda A., Opavsky MA, Chandrasekhar Y.Bimodal effects of luteinizing hormone and role of androgens in modifying superovulatory responses of rats to infusion with purified porcine follicle-stimulating hormone . Biol Reprod1989;41:51-62.
89.
Hillier SG, Ross GTEffects of exogenous testosterone on ovarian weight, follicular morphology and intraovarian progesterone concentration in estrogen-primed, hypophysectomized rats. Biol Reprod1979;20:261-8.
90.
Palumbo A., Pourmotabbed G., Carcangiu ML, et al. Immunohistochemical localization of renin and angiotensin in the ovary: Comparison between normal women and patients with histologically proven polycystic ovarian disease. Fertil Steril1993;60:280-4.
91.
Lightman A. , Jones C., McLusky NJ, Palumbo A., Naftolin F.Immunocytochemical localization of angiotensin II immunoreactivity and demonstration of angiotensin II binding in the rat ovary. Am J Obstet Gynecol1988 ;159:526-30.
92.
Mukhopadhyay AK, Holstein K., Szkudlinski M., Brunswig-Spickenheier B., Leidenberger FAThe relationship between prorenin levels in follicular fluid and follicular atresia in bovine ovaries. Endocrinology1991 ;129:2367-75.
93.
Schultze D. , Brunswig B., Mukhopadhyay AKRenin and prorenin-like activities in bovine ovarian follicles. Endocrinology1989;124:1389-98.
94.
Cedars MI, Steingold KA, de Zeigler D., Lapolt PS, Chang RJ, Judd HLLong-term administration of gonadotropin-releasing hormone agonist and dexamethasone: Assessment of the adrenal role in ovarian dysfunction. Fertil Steril1988;57:495-500.
95.
Short RVFurther observations on the defective synthesis of ovarian steroids in the Stein-Leventhal syndrome. J Endocrinol1962 ;24:359-65.
96.
Erickson GF , Hsueh Ajw, Quigley ME, Rebard RW, Yen Ssc.Functional studies of aromatase activity in human granulosa cells from normal and polycystic ovaries. J Clin Endocrinol Metab1990;49:514-9.
97.
Axelrod LR, Goldzieher.Enzyme inadequacies of human polycystic ovaries. Arch Biochem Biophys1961 ;95:547-51.
98.
Mahesh V., Greenblat RBSteroid secretions of the normal and polycystic ovary. Recent Prog Horm Res1964;20: 341-94.
99.
Haning Evj, Strawn EY, Nolten WEPathophysiology of the ovarian hyperstimulation syndrome. Obstet Gynecol1985;66:220.
100.
Navot D., Margolith EJ, Laufer N., et al. Direct correlation between plasma renin activity and severity of the ovarian hyperstimulation syndrome. Fertil Steril1987;48:57-61.
